Research explores how genetic variation remodels cardiomyocyte architecture, adhesion, and mechano‑signaling to drive cardiomyopathy. Uses functional genomics, cell biomechanics, and advanced imaging to link genotype to phenotype and reveal mechanisms, biomarkers, and potential therapeutic targets.